Orriant Revenue and Competitors

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • Orriant's estimated annual revenue is currently $14.1M per year.(i)
  • Orriant's estimated revenue per employee is $243,000

Employee Data

  • Orriant has 58 Employees.(i)
  • Orriant grew their employee count by -2% last year.

Orriant's People

NameTitleEmail/Phone
1
Director Innovation and ImprovementReveal Email/Phone
2
Director PeopleReveal Email/Phone
3
Clinical ManagerReveal Email/Phone
4
Assessment ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.1M336%N/AN/A
#2
$8.4M39-2%N/AN/A
#3
$61.8M20812%N/AN/A
#4
$12.9M530%N/AN/A
#5
$9.9M46N/AN/AN/A
#6
$7.3M343%N/AN/A
#7
$208.6M6188%N/AN/A
#8
$17M7030%N/AN/A
#9
$135.7M4021%N/AN/A
#10
$476.1M123310%$580MN/A
Add Company

What Is Orriant?

Orriant: Corporate Wellness Company Orriant’s unique model incorporates biometric testing, individualized health coaching and a personal wellness profile with a financial incentive. Orriant is a term that means “To rise up and be of good cheer.” We believe that wellness is the key to enduring happiness for all people, young and old. Orriant strives to provide increased wellness for individuals, for businesses, and for the community as a whole. It is our goal to pass on physical, mental, and fiscal wellness opportunities to the American workforce. Orriant is a company dedicated to getting America: to rise up off the couch and be more active, to rise up and change the way they pay for health care, to rise up and reach higher levels of health, to rise up and deal with the health care cost crisis, and to rise up to higher quality of life. Orriant is where health comes to life.

keywords:N/A

N/A

Total Funding

58

Number of Employees

$14.1M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.1M585%N/A
#2
$9.3M597%N/A
#3
$14.8M6111%N/A
#4
$8.9M6213%N/A
#5
$14.3M6313%N/A